Purchase Order HHSN272201100332P
- Not listed
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for $6,264.00. The contract is for the provision of "TRUSEQ RNA SAMPLE BIOLOGICAL REAGENTS" and does not have a set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of providing sequencing systems,...
- This is a $11,439.25 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Illumina, Inc. for ILLUMINA TRUSEQ REAGENT KITS. The award has no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, has previously received prime federal contracts and sub-awards from agencies like the NIH, CDC, USDA, and VA to support their genomic sequencing and analysis...
- This firm fixed-price purchase order was awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services (HHS). The $3,421.50 contract is for the provision of TRUSEQ KITS, with a period of performance ending on July 21, 2015. The award did not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
- This is a $15,395.83 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for TruSeq reagent kits. The award has no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has previously received prime contracts and subcontracts from federal agencies like NIH, CDC, USDA, and VA to provide a range of sequencing...
- This federal contract award to Illumina, Inc. is for the provision of TRUSEQ RNA SAMPLE PREP KITS, catalog number FC-122-1001, to the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). The $3,277.98 firm fixed price delivery order has an ultimate completion date of August 31, 2015. Illumina, a manufacturer of sequencing and genomic analysis solutions, has previously provided a range of sequencing systems, reagents, and services to NIAID,...
- This firm fixed-price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $8,366.17 award is for the procurement of Illumina's TruSeq DNA Sample Prep Kit Set A, which supports sample preparation for genomic sequencing. Illumina has a history of prime federal contract and subcontract...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of the TruSeq RNA Sample Prep Kit. The award has a ceiling value of $3,258.00 and a completion date of March 26, 2015. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis that has received past prime federal contract awards from...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The contract, valued at $12,697.30, has no set-aside designation and is for the ultimate completion of the order by September 5, 2014. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has a history of providing...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $5,626.82 firm fixed price delivery order is for the purchase of Illumina's TruSeq SBS Kit v3 - HS - 50-Cycle, which supports high-throughput DNA sequencing. The award has no set-aside designation and appears to align with NIAID's mission to support...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The award, valued at $5,277.25, is for the provision of sequencing kits to support NIAID's research and diagnostics work. Illumina has been a long-standing provider of sequencing solutions to various federal agencies including the Centers for...
This $3,277.99 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The award is for the provision of a TRUSEQ RNA SAMPLE KIT to support NIAID's research and development activities. No set-aside designation is mentioned. Illumina has received multiple prior federal contract awards from agencies like the NIH, Centers for Disease Control and Prevention (CDC), Department of Agriculture (USDA), and Department of Veterans Affairs (VA) to provide sequencing systems, reagents, and related services for genomics research and diagnostics. This award appears to be part of Illumina's Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, which provides nucleic acid sequencing capabilities for the Naval Medical Research Center.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Funding Only Action | ($22) | 9/29/15 | |
| Not listed | Not listed | $3.3k | 3/1/11 |